On the evening of April 26, Yiling Pharmaceutical (002603) released its 2023 annual report. According to the annual report, in 2023, Yiling Pharmaceutical will achieve operating income of 10.318 billion yuan and R&D investment of 935 million yuan, accounting for 9% of revenue. Its cardiovascular and cerebrovascular and respiratory disease products still dominate the market, thanks to the company's strong core competitiveness, which lays confidence in the consumer terminal of the product. This article will interpret the key to the success of Yiling Pharmaceutical from the eight core competitiveness of theoretical system advantages, product advantages, professional promotion advantages, R&D advantages, product intellectual property advantages, resource integration advantages, talent advantages, and brand advantages.
The advantages of the theoretical system of network disease are unique in the pharmaceutical industry
As an important part of the academic theoretical system of traditional Chinese medicine, after more than 30 years of painstaking research, Yiling Pharmaceutical has constructed a theoretical system of network disease for the first time, created a new discipline of traditional Chinese medicine and formed two branches of science - the theory of pulse and the theory of qi.
Yiling Pharmaceutical Co., Ltd. published three monographs: "Complex Disease", "Theory of Qi Circulation" and "Theory of Context".
With the theory of vein to guide the prevention and treatment of vascular diseases, a number of patented new drugs have been developed, such as Tongxinluo Capsule, a representative drug for the treatment of cardiovascular and cerebrovascular diseases, Ginseng Song Yangxin Capsule, a representative drug for the treatment of arrhythmia, and Qili Qiangxin Capsule, which is a specimen and chronic heart failure, which inhibit the occurrence of cardiovascular and cerebrovascular event chains, play a major role in the prevention and treatment of cardiovascular and cerebrovascular diseases, and show the clinical application value of the theory of network disease to guide the prevention and treatment of a variety of major diseases. "The construction of the context theory of traditional Chinese medicine to promote the prevention and treatment of microvascular lesions" was selected as a landmark scientific and technological achievement of traditional Chinese medicine in the new era, ranking first in the first major category of "the formation of new theories and new disciplines of traditional Chinese medicine".
Based on the guidance of the theory of network disease and the treatment of lung network disease, Lianhua Qingwen capsules/granules have been developed to treat influenza, cold and new coronavirus infection, and Lianhua Qingcough tablets to treat acute tracheobronchitis.
With the theory of qi network to guide the prevention and treatment of neuro-endocrine-immune diseases, we have developed Jinlida granules for the treatment of type 2 diabetes, Tongluo Mingmu capsules for the treatment of moderate non-proliferative diabetic retinopathy caused by type 2 diabetes, Yangzheng Xiaoji capsules for the treatment of tumors, Xia Liqi capsules for the treatment of prostatic hyperplasia, kidney and heart soothing tablets for the treatment of insomnia, and anti-depression capsules for the treatment of depression.
After the new drug is launched, it cooperates with domestic experts in related fields to carry out a series of basic experimental research and clinical evidence-based research in line with international evidence-based medicine standards, and creates a new model of TCM innovation and transformation integrating "theory + clinical + new drug + experiment + evidence-based", which combines the traditional theoretical innovation of TCM with modern science and technology, produces major original achievements, and makes a demonstration for the inheritance and innovative development of TCM. Based on the above-mentioned scientific and technological advantages, Yiling Pharmaceutical has presided over the completion of more than 60 national, provincial and ministerial projects such as the national "973" plan (2), the national "863" plan, and the national key research and development plan, and has won 1 first prize of the National Science and Technology Progress Award, 4 second prizes of the National Science and Technology Progress Award, and 1 second prize of the National Technological Invention Award.
The advantages of the product matrix, covering a wide range of disease areas, have broad market prospects
The company drives the industrialization of traditional Chinese medicine with the theoretical innovation of network disease, uses modern high-tech research and development of innovative traditional Chinese medicine, and develops 14 national patented new drugs, of which 10 are listed in the national medical insurance catalog, 5 are listed in the national essential drug list, and 10 are listed in the expert consensus, diagnosis and treatment guidelines, and recommended drugs in college textbooks, all of which are listed in the national key new products. The products cover cardiovascular and cerebrovascular diseases, respiratory diseases, tumors, diabetes, nervous system diseases, urological diseases and other major diseases, with complete product layout and reasonable echelon, which has laid a solid foundation for the company's future development. Yiling Pharmaceutical's leading products are all exclusive products, with unique formulas, and occupy a unique academic position and market position in multiple disease fields.
A number of the company's patented products have been randomized, double-blind controlled, multi-center evidence-based medical research, and some of the research results have been published in international authoritative journals, which have had a significant impact on the medical community at home and abroad, providing a strong impetus for the academic promotion of the company's products, and laying a good foundation for the company to continue to maintain sustainable growth in the next few years.
Promote the advantages of specialization and promote the vigorous development of academic theories
At present, the company has promoted the establishment of an "international-national-provincial-municipal" four-level society organization system, and established the Canadian, European and American Networks Disease Society, the Chinese Association of Traditional Chinese Medicine, the Vascular Choroid Disease Professional Committee of the Chinese Association of Integrative Medicine, The World Federation of Chinese Medicine Societies and the Anti-Aging Professional Committee and more than 130 provincial and municipal professional committees of the Association of Diseases have built a good platform for the academic promotion of the theory of the disease, formed a team of tens of thousands of experts in the study of the disease, and effectively promoted the integration of traditional Chinese and Western medicine in the field of related diseases.
The company has established a nationwide sales channel and terminal network, which has become an important guarantee to ensure the company's comprehensive competitiveness.
The advantages of product and technology research and development have laid a fertile ground for the continuous research and development of innovative drugs
Yiling Pharmaceutical adheres to scientific and technological innovation to promote the rapid development of enterprises, and has established a new drug research and development technology system guided by the theoretical innovation of traditional Chinese medicine, and has the ability to research and develop new drugs of compound Chinese medicine, component Chinese medicine and monomer Chinese medicine, and its technological achievements are in a leading position in the same industry in China.
In 2023, Yiling Pharmaceutical's R&D investment will be 935 million, a year-on-year increase of 4.41%, maintaining a sustained growth trend. The company actively builds various innovation platforms, has a national enterprise technology center, a national key laboratory for the innovation and transformation of network disease theory, etc., and has set up a pharmaceutical research institute as the main body of research and development to engage in new drug research and development and innovation research, with a branch of traditional Chinese medicine, a branch of chemical medicine, a health branch, a new drug evaluation center, a new drug clinical center, a domestic registration center, an international registration center and other functional departments, through short-term, medium-term and long-term research and development planning and investment, the layout of the company's future research and development innovation driving force.
Intellectual property advantages, exclusive patented products are more competitive in the market
In view of the state's protection of innovative drugs, Yiling Pharmaceutical has established a professional intellectual property management department in order to effectively strengthen its own intellectual property protection, and as of the end of the reporting period, the company has 848 valid patents.
The advantages of resource integration and the competitiveness of multiple formats continue to emerge
Based on the R&D, production and sales of patented Chinese medicines, the company extends the company's business segment to the chemical and biological drugs and health industry, and establishes a business development model that combines online and offline sales, domestic and international markets, and complements drug sales and health industries, forming the core competitiveness of advantageous resource integration.
Talent advantages, absorb scientific and technological talents at home and abroad, and inject endogenous power into the research and development of innovative drugs
The company has established a high-quality scientific research and management team, and has formed a R&D team with academicians as academic leaders, returned experts, foreign experts, doctors, masters and other high-level talents as the backbone, with reasonable knowledge structure, scientific age echelon, and multidisciplinary advantage combination, which is included in the first batch of "Giant Plan" teams in Hebei Province, and has won the honorary title of "high-level innovation team", and has sufficient strength to carry out innovative drug research and development. In terms of management team, the company adopts a complementary model combining independent training + foreign introduction to build a high-level, high-quality, and experienced professional management team to lay the foundation for the company's sustainable development.
With the blessing of brand advantages, it helps the highly elastic growth of innovative Chinese medicine
The company fully implements the brand marketing strategy and is committed to the strategic transformation from product management to brand management. Always adhere to the academic brand and social brand to promote each other, common promotion, through the integration of enterprise scientific and technological innovation, product quality, social responsibility, corporate culture and other advantageous resources, and constantly transform scientific and technological advantages, product characteristics, product quality, social responsibility into corporate social brand. After years of development, the company's "scientific and technological innovation + quality assurance + social responsibility" brand building has achieved remarkable results, and has become a scientific and technological innovation enterprise with a high reputation in the pharmaceutical industry.
After more than 30 years of development, Yiling Pharmaceutical has become an industry leader because of its above eight advantages. In the future, Yiling Pharmaceutical will continue to promote the development process of traditional Chinese medicine with greater efforts and more practical measures, and help the big ship of modernization, internationalization and industrialization of traditional Chinese medicine to "ride the wind and waves forward"!
![The liver fire is strong and irritable?Chinese medicine fire reduction method to help you calm your emotions![fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)